【China Chemical & Pharmaceutical Co., Ltd. Biotech】Q1 2026 EPS NT$1.64

Key facts

  • 【China Chemical & Pharmaceutical Co., Ltd. Biotech】Q1 2026 EPS NT$1.64
  • China Chemical & Pharmaceutical Co., Ltd. Biotech (1762) announced strong financial results for Q1 2026, achieving revenue of NT$361 million, net profit of NT$91 million, and a high earnings per share (EPS) of NT$1.64, indicating strong profitability and growth.
  • Source: PR Times
  • Date: March 1, 2026

Direct answer

China Chemical & Pharmaceutical Co., Ltd. Biotech (1762) announced strong financial results for Q1 2026, achieving revenue of NT$361 million, net profit of NT$91 million, and a high earnings per share (EPS) of NT$1.64, indicating strong profitability and growth.

Citation
【China Chemical & Pharmaceutical Co., Ltd. Biotech】Q1 2026 EPS NT$1.64 (March 1, 2026), PR Times
Source
PR Times
Date
March 1, 2026
China Chemical & Pharmaceutical Co., Ltd. Biotech (1762) announced strong financial results for Q1 2026, achieving revenue of NT$361 million, net profit of NT$91 million, and a high earnings per share (EPS) of NT$1.64, indicating strong profitability and growth.
その他NQ 0/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: May 15, 2026 at 08:01 (1799h 1m after Published)
  • 🤖 AI Analyzed: May 15, 2026 at 09:22 (1h 21m after Collected)
Company Code: 1762
Company Name: China Chemical & Pharmaceutical Co., Ltd. Biotech
Industry: Biotechnology and Medical Care
Year/Quarter: 2026 Q1
Basic Earnings Per Share: NT$1.64
Operating Revenue: NT$361 million
Net Profit After Tax: NT$91 million

FAQ

What are the key facts in this article?

China Chemical & Pharmaceutical Co., Ltd. Biotech (1762) announced strong financial results for Q1 2026, achieving revenue of NT$361 million, net profit of NT$91 million, and a high earnings per share (EPS) of NT$1.64, indicating strong profitability and growth.

What is the direct answer?

China Chemical & Pharmaceutical Co., Ltd. Biotech (1762) announced strong financial results for Q1 2026, achieving revenue of NT$361 million, net profit of NT$91 million, and a high earnings per share (EPS) of NT$1.64, indicating strong profitability and growth.

What is the source and date?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-1762-2026Q1 | March 1, 2026

Back to Newsroom (15)